Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis

Authors

Firas Abdollah, Henry Ford HealthFollow
Maxine Sun
Jesse D. Sammon, Henry Ford Health
Toni K. Choueiri
Mani Menon, Henry Ford HealthFollow
Joel S. Weissman
Quoc-Dien Trinh

Recommended Citation

Abdollah F, Sun M, Sammon JD, Choueiri TK, Menon M, Weissman JS, and Trinh QD. Prevalence of nonrecommended screening for prostate cancer and breast cancer in the United States: A nationwide survey analysis. JAMA Oncol 2016; 2(4):543-545.

Document Type

Article

Publication Date

4-1-2016

Publication Title

JAMA Oncol

Medical Subject Headings

Aged; Breast Neoplasms/diagnosis; Early Detection of Cancer/statistics & numerical data; Female; Humans; Male; Mammography/statistics & numerical data; Prevalence; Prostate-Specific Antigen/blood; Prostatic Neoplasms/diagnosis; Surveys and Questionnaires; United States

PubMed ID

26794060

Volume

2

Issue

4

First Page

543

Last Page

545